Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MHC antigens on human tumors.

F Ruiz-Cabello1, E Klein, F Garrido

  • 1Departamento de Análisis Clínicos e Inmunología, Hospital Virgen de las Nieves, Universidad de Granada, Spain.

Immunology Letters
|August 1, 1991
PubMed
Summary

Changes in human leukocyte antigen (HLA) expression on tumor cells impact immune response and tumor behavior. Understanding these alterations is key to developing effective cancer immunotherapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of cytotoxicity with various MHC class I restrictions against autologous LCL by stimulating the lymphocytes with autologous and/or allogeneic LCLs sharing HLA alleles with the responder.

Cellular immunology·1992
Same author

HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.

International journal of cancer·1992
Same author

[Urinary excretion of mineral arsenic, methylarsonic acid and dimethylarsinic acid in workers exposed to gallium arsenide].

Journal de toxicologie clinique et experimentale·1992
Same author

A trypsin-like serine protease activity on activated human B cells and various B cell lines.

European journal of immunology·1992
Same author

Characteristic ionic composition of endolymph is maintained in cultured inner ear.

Acta oto-laryngologica·1992
Same author

MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).

International journal of cancer·1992

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • MHC class I antigens on tumor cells are crucial for regulating sensitivity to anti-tumor immune responses.
  • Alterations in MHC expression can affect tumor cell recognition by the immune system, influencing T and NK cell activity.
  • While MHC class I changes are studied in experimental models, less is known about selective losses in human tumors.

Purpose of the Study:

  • To investigate the influence of selective loss of individual human leukocyte antigen (HLA) locus products on human tumor cell behavior.
  • To explore the association between HLA loss and tumor differentiation or prognosis.
  • To examine the potential immunological role of HLA class II expression in neoplastic cells.

Main Methods:

  • Analysis of total and selective HLA losses in various human tumors.
  • Investigation of mechanisms underlying HLA expression changes.
  • Correlation of HLA expression patterns with tumor differentiation and prognosis.

Main Results:

  • Total and selective HLA losses are observed in diverse human tumors, driven by various mechanisms.
  • Some HLA losses correlate with poor tissue differentiation and prognosis, while others do not.
  • HLA class II expression is often associated with a more favorable prognosis in tumors, except for melanoma.

Conclusions:

  • Selective loss of HLA antigens significantly impacts human tumor behavior and immune evasion.
  • Further research is needed to understand the prognostic implications of specific HLA loss patterns.
  • Manipulating MHC class I and II antigen expression in tumors could be a strategy to enhance anti-tumor immune responses.

Related Experiment Videos